Insider Transactions

What Day One Biopharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	9
Total trades	0	63

Shares traded

	3 months	12 months
Acquired	0	776,254
Disposed	0	16,026,625
Net activity	+0	−15,250,371

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Ramasastry Saira	Director	Apr 23	Disposition to Issuer · D	−40,485	—	—	0
Holles Natalie C.	Director	Apr 23	Disposition to Issuer · D	−57,310	—	—	0
York Charles N Ii	COO and CFO	Apr 23	Disposition to Issuer · D	−312,025	—	—	0
Vasconcelles Michael	Head of Research and Dev.	Apr 23	Disposition to Issuer · D	−4,397	—	—	0
Dubow Adam	Gen Counsel & Secretary	Apr 23	Disposition to Issuer · D	−72,694	—	—	0
Josey John A.	Director	Apr 23	Disposition to Issuer · D	−72,292	—	—	0
Merendino Lauren	Chief Commercial Officer	Apr 23	Disposition to Issuer · D	−60,157	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−808,285	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−300,000	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−18,197	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−147,702	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−300,000	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−20,204	—	—	0
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Apr 23	Disposition to Issuer · D	−204,643	—	—	0
Ai Day 1 Llc	10% owner	Apr 23	Tender Offer · U	−12,929,322	$21.50	−$278M	0
York Charles N Ii	COO and CFO	Feb 17	Open-market sale · S	−6,065	$11.60	−$70.4K	312,025
Vasconcelles Michael	Head of Research and Dev.	Feb 17	Open-market sale · S	−2,728	$11.60	−$31.6K	4,397
Dubow Adam	Gen Counsel & Secretary	Feb 17	Open-market sale · S	−6,395	$11.60	−$74.2K	72,694
Merendino Lauren	Chief Commercial Officer	Feb 17	Open-market sale · S	−5,814	$11.60	−$67.4K	60,157
Bender Jeremy	CHIEF EXECUTIVE OFFICER	Feb 17	Open-market sale · S	−15,459	$11.60	−$179K	204,603

Page 1 of 22 · showing the 20 most recent Sign up free to view all 422 transactions and filter by insider →

Comments